X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32270) 32270
Newsletter (1714) 1714
Newspaper Article (601) 601
Book Chapter (227) 227
Publication (126) 126
Dissertation (102) 102
Magazine Article (72) 72
Book / eBook (25) 25
Web Resource (21) 21
Conference Proceeding (20) 20
Reference (8) 8
Trade Publication Article (6) 6
Book Review (3) 3
Journal / eJournal (3) 3
Streaming Video (3) 3
Transcript (3) 3
Government Document (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23858) 23858
chronic lymphocytic-leukemia (11336) 11336
hematology (10731) 10731
male (10251) 10251
oncology (9946) 9946
chronic lymphocytic leukemia (9686) 9686
female (9390) 9390
middle aged (8437) 8437
aged (7908) 7908
cancer (6867) 6867
adult (5728) 5728
leukemia (5422) 5422
leukemia, lymphocytic, chronic, b-cell - pathology (4464) 4464
research (4422) 4422
leukemia, lymphocytic, chronic, b-cell - drug therapy (3974) 3974
leukemia, lymphocytic, chronic, b-cell - genetics (3974) 3974
prognosis (3704) 3704
animals (3625) 3625
aged, 80 and over (3610) 3610
apoptosis (3402) 3402
care and treatment (3063) 3063
expression (2946) 2946
lymphoma (2531) 2531
rituximab (2529) 2529
cll (2452) 2452
leukemia, lymphocytic, chronic, b-cell - immunology (2393) 2393
antineoplastic agents - therapeutic use (2335) 2335
lymphomas (2331) 2331
survival (2249) 2249
hemic and lymphatic diseases (2203) 2203
treatment outcome (2177) 2177
immunology (2173) 2173
mutation (2125) 2125
genetic aspects (2095) 2095
oncology, experimental (2083) 2083
leukemia, lymphocytic, chronic, b-cell - metabolism (2072) 2072
therapy (1961) 1961
analysis (1955) 1955
chemotherapy (1893) 1893
fludarabine (1872) 1872
leukemia, lymphocytic, chronic, b-cell - diagnosis (1811) 1811
chronic lymphatic leukemia (1800) 1800
flow cytometry (1790) 1790
diagnosis (1755) 1755
health aspects (1746) 1746
mice (1713) 1713
antineoplastic combined chemotherapy protocols - therapeutic use (1711) 1711
cell biology (1671) 1671
risk factors (1625) 1625
pathology (1534) 1534
leukemia, lymphocytic, chronic, b-cell - complications (1500) 1500
leukemia, lymphocytic, chronic, b-cell - therapy (1482) 1482
acute lymphoblastic-leukemia (1452) 1452
gene expression (1438) 1438
cell line, tumor (1415) 1415
non-hodgkins-lymphoma (1401) 1401
abridged index medicus (1367) 1367
chronic lymphocytic leukaemia (1366) 1366
antineoplastic agents - pharmacology (1360) 1360
disease (1340) 1340
pharmacology & pharmacy (1336) 1336
activation (1329) 1329
biochemistry & molecular biology (1329) 1329
vidarabine - analogs & derivatives (1322) 1322
disease progression (1318) 1318
acute myeloid-leukemia (1314) 1314
leukemia, lymphocytic, chronic, b-cell - mortality (1291) 1291
immunotherapy (1284) 1284
apoptosis - drug effects (1280) 1280
proteins (1266) 1266
medicine, research & experimental (1240) 1240
adolescent (1212) 1212
patients (1199) 1199
immunophenotyping (1197) 1197
chronic myelogenous leukemia (1186) 1186
drug therapy (1181) 1181
transplantation (1181) 1181
tumor cells, cultured (1181) 1181
cells (1171) 1171
tumors (1164) 1164
medicine & public health (1161) 1161
lymphatic leukemia (1153) 1153
b-lymphocytes - immunology (1135) 1135
signal transduction (1134) 1134
hematology, oncology and palliative medicine (1114) 1114
lymphocytes (1079) 1079
development and progression (1074) 1074
antibodies, monoclonal - therapeutic use (1073) 1073
retrospective studies (1063) 1063
in-vitro (1039) 1039
leukemia, lymphocytic, chronic, b-cell - blood (1034) 1034
chronic myeloid-leukemia (1031) 1031
b-cells (1010) 1010
b cells (1006) 1006
genes (1002) 1002
b-cell lymphoma (992) 992
cyclophosphamide (983) 983
multiple-myeloma (971) 971
genetics & heredity (959) 959
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (14) 14
Gerstein Science - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33789) 33789
French (290) 290
Chinese (187) 187
Polish (177) 177
German (170) 170
Russian (157) 157
Japanese (150) 150
Spanish (141) 141
Czech (93) 93
Hungarian (41) 41
Portuguese (26) 26
Turkish (25) 25
Korean (21) 21
Italian (18) 18
Serbian (12) 12
Slovak (9) 9
Slovenian (9) 9
Croatian (8) 8
Danish (7) 7
Persian (6) 6
Dutch (5) 5
Hebrew (4) 4
Norwegian (4) 4
Romanian (4) 4
Finnish (2) 2
Icelandic (2) 2
Arabic (1) 1
Bulgarian (1) 1
Catalan (1) 1
Esperanto (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 4, pp. 323 - 332
.... It had substantial antitumor effects in a phase 1–2 study involving patients with relapsed chronic lymphocytic leukemia... 
B-CELL RECEPTOR | MEDICINE, GENERAL & INTERNAL | ACTIVATION | IN-VIVO | X-LINKED AGAMMAGLOBULINEMIA | IBRUTINIB | BTK | PCI-32765 | TYROSINE KINASE INHIBITOR | LYMPHOMA | OPEN-LABEL | Recurrence | Benzamides - pharmacokinetics | Humans | Middle Aged | Pyrazines - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Benzamides - adverse effects | Headache - chemically induced | Chromosome Deletion | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Agammaglobulinaemia Tyrosine Kinase | Pyrazines - pharmacokinetics | Pyrazines - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Treatment outcome | Usage | Care and treatment | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Pharmacology | Dosage and administration | Pharmacokinetics | Antineoplastic agents | Tyrosine | Headache | Pharmacodynamics | Transformation | Chronic lymphatic leukemia | Inhibitor drugs | Leukemia | Diarrhea | Chromosome deletion | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Clonal deletion | Lymphomas | Safety | Drug therapy | Lymphocytosis | Protein-tyrosine kinase | Chromosome 17 | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 12, pp. 1107 - 1120
In a trial involving patients with relapsed or refractory chronic lymphocytic leukemia, the BCL2 inhibitor venetoclax in combination with rituximab resulted in a higher 2-year rate of progression-free... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | 17P DELETION | TARGETING BCL2 | PLUS RITUXIMAB | TP53 MUTATION | PROGRESSION-FREE | OPEN-LABEL | MINIMAL RESIDUAL DISEASE | Recurrence | Bendamustine Hydrochloride - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Neoplasm, Residual | Young Adult | Bendamustine Hydrochloride - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Tumor Lysis Syndrome - etiology | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Rituximab - adverse effects | Kaplan-Meier Estimate | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sulfonamides - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Sulfonamides - administration & dosage | Treatment outcome | Chronic lymphocytic leukemia | Diagnosis | Analysis | Chronic lymphatic leukemia | Cell survival | Hematology | Leukemia | Rituximab | Clinical trials | Oncology | Chromosome deletion | Lymphatic leukemia | Patients | Cancer therapies | Evidence-based medicine | Chemotherapy | Clonal deletion | Lysis | Response rates | Bone marrow | Chromosomes | Drug dosages | Chromosome 17 | Neutropenia | Life Sciences
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 5, pp. 432 - 443
Journal Article
9.